Vor Biopharma (VOR) Stock: Buy, Sell, or Hold?
VOR - Vor Biopharma Inc. Common Stock
$18.69
0.63 (3.49%)
▲
5d:
+0.92%
30d:
-24.52%
90d:
-7.01%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When VOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VOR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VOR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VOR is currently trading at $18.69, which is considered oversold relative to its 30-day fair value range of $20.23 to $24.18.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $17.52, while resistance sits at $23.82. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: VOR scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $39.00 (+108.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $17.52, while resistance sits at $23.82. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: VOR scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $39.00 (+108.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.23 -
$24.18
Company Quality Score
72/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 108.7% below Wall St target ($39.00)
- CAUTION: Bottoming setup, but lagging the sector by 37% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$20.23 -
$24.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$17.52
Resistance Level
$23.82
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.90
Wall Street Target
$39.00
(+108.7%)
Share & Embed Analysis
Last updated: October 03, 2026 12:09 PM ET
Data refreshes hourly during market hours. Next update: 1:09 PM
Data refreshes hourly during market hours. Next update: 1:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VOR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Ra Capital Management, L…
SELL
165150 shares
2026-04-22
Ra Capital Management, L…
SELL
171963 shares
2026-04-20
Ra Capital Management, L…
SELL
458411 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 52 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$47 | 46 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$139 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$118 | 55 HOLD |
